TCON - トラコン・ファ―マシュ―ティカルズ (TRACON Pharmaceuticals Inc.)

TCONのニュース

   TRACON to Report First Quarter 2020 Financial Results and Company Highlights on May 13, 2020  2020/05/06 20:05:00 GlobeNewswire
SAN DIEGO, May 06, 2020 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development…
   Tracon stock rises on cancer development partnerships  2019/12/20 13:58:00 MarketWatch
Shares of Tracon Pharmaceuticals Inc. were up 29% in premarket trading on Friday after the company said it would partner with two Chinese companies to…
   TRACON Pharmaceuticals (NASDAQ:TCON) Releases Quarterly Earnings Results, Beats Estimates By $0.03 EPS  2019/11/07 15:51:11 Modern Readers
TRACON Pharmaceuticals (NASDAQ:TCON) announced its quarterly earnings results on Tuesday. The biopharmaceutical company reported ($0.17) earnings per share for the quarter, beating the consensus estimate of ($0.20) by $0.03, Fidelity Earnings reports. NASDAQ TCON traded down $0.02 during trading hours on Thursday, reaching $0.40. The company had a trading volume of 368 shares, compared to […]
   Tracon Pharma Shares Rally As First Patient Dosed In Cancer Trial  2019/08/01 15:33:40 Benzinga
Shares of the thinly traded nanocap biotech TRACON Pharmaceuticals Inc (NASDAQ: TCON ) were rallying Thursday. What Happened Tracon, which specializes in novel therapeutics for cancer, said it has dosed the first patient in a U.S. Phase 1 first-in-human clinical trial of I-Mab's proprietary CD73 antibody TJD5, also known as TJ004309, in patients with advanced solid tumors. TJD5 is from Chinese biopharma stable and it is being co-developed through a corporate collaboration between Tracon and I-Mab that was signed in November 2018. TJD5 will be dosed in the Phase 1 trial both as a single agent … Full story available on Benzinga.com
   The Daily Biotech Pulse: Roche-Spark Deal Faces Further Delay, Bayer's Prostate Cancer Drug Passes FDA Muster  2019/07/31 11:06:00 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on July 30) Acasti Pharma Inc (NASDAQ: ACST ) ANI Pharmaceuticals Inc Common Stock (NASDAQ: ANIP ) Arcturus Therapeutics Ltd (NASDAQ: ARCT ) Hologic, Inc. (NASDAQ: HOLX ) Insulet Corporation (NASDAQ: PODD ) Medpace Holdings Inc (NASDAQ: MEDP )(reported strong second-quarter results ) Novocure Ltd (NASDAQ: NVCR ) ZIOPHARM Oncology Inc. (NASDAQ: ZIOP ) Down In The Dumps (Biotech stocks hitting 52-week lows on July 30) Alimera Sciences Inc (NASDAQ: ALIM )(reacted to second-quarter results) ANCHIANO THERAP/S ADR (NASDAQ: ANCN ) Aquestive Therapeutics Inc (NASDAQ: AQST ) Champions Oncology Inc (NASDAQ: CSBR ) China SXT Pharmaceuticals Inc (NASDAQ: SXTC ) Equillium Inc (NASDAQ: EQ ) Medtronic PLC (NYSE: MDT ) Obseva SA (NASDAQ: OBSV ) Rhythm Pharmaceuticals Inc (NASDAQ: RYTM ) TRACON Pharmaceuticals Inc (NASDAQ: TCON ) Trevi Therapeutics Inc (NASDAQ: TRVI ) Zimmer Biomet Holdings Inc (NYSE: ZBH ) Stocks In Focus Roche Extends Offer Period For Spark Buy Once Again Roche Holdings AG Basel ADR (OTC: RHHBY ) and Spark Therapeutics Inc (NASDAQ: ONCE ) announced Wednesday Roche has extended the offering period for its previously announced tender offer to buy all outstanding shares of Spark for $114.50 …
   TRACON to Report First Quarter 2020 Financial Results and Company Highlights on May 13, 2020  2020/05/06 20:05:00 GlobeNewswire
SAN DIEGO, May 06, 2020 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development…
   Tracon stock rises on cancer development partnerships  2019/12/20 13:58:00 MarketWatch
Shares of Tracon Pharmaceuticals Inc. were up 29% in premarket trading on Friday after the company said it would partner with two Chinese companies to…
   TRACON Pharmaceuticals (NASDAQ:TCON) Releases Quarterly Earnings Results, Beats Estimates By $0.03 EPS  2019/11/07 15:51:11 Modern Readers
TRACON Pharmaceuticals (NASDAQ:TCON) announced its quarterly earnings results on Tuesday. The biopharmaceutical company reported ($0.17) earnings per share for the quarter, beating the consensus estimate of ($0.20) by $0.03, Fidelity Earnings reports. NASDAQ TCON traded down $0.02 during trading hours on Thursday, reaching $0.40. The company had a trading volume of 368 shares, compared to […]
   Tracon Pharma Shares Rally As First Patient Dosed In Cancer Trial  2019/08/01 15:33:40 Benzinga
Shares of the thinly traded nanocap biotech TRACON Pharmaceuticals Inc (NASDAQ: TCON ) were rallying Thursday. What Happened Tracon, which specializes in novel therapeutics for cancer, said it has dosed the first patient in a U.S. Phase 1 first-in-human clinical trial of I-Mab's proprietary CD73 antibody TJD5, also known as TJ004309, in patients with advanced solid tumors. TJD5 is from Chinese biopharma stable and it is being co-developed through a corporate collaboration between Tracon and I-Mab that was signed in November 2018. TJD5 will be dosed in the Phase 1 trial both as a single agent … Full story available on Benzinga.com
   The Daily Biotech Pulse: Roche-Spark Deal Faces Further Delay, Bayer's Prostate Cancer Drug Passes FDA Muster  2019/07/31 11:06:00 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on July 30) Acasti Pharma Inc (NASDAQ: ACST ) ANI Pharmaceuticals Inc Common Stock (NASDAQ: ANIP ) Arcturus Therapeutics Ltd (NASDAQ: ARCT ) Hologic, Inc. (NASDAQ: HOLX ) Insulet Corporation (NASDAQ: PODD ) Medpace Holdings Inc (NASDAQ: MEDP )(reported strong second-quarter results ) Novocure Ltd (NASDAQ: NVCR ) ZIOPHARM Oncology Inc. (NASDAQ: ZIOP ) Down In The Dumps (Biotech stocks hitting 52-week lows on July 30) Alimera Sciences Inc (NASDAQ: ALIM )(reacted to second-quarter results) ANCHIANO THERAP/S ADR (NASDAQ: ANCN ) Aquestive Therapeutics Inc (NASDAQ: AQST ) Champions Oncology Inc (NASDAQ: CSBR ) China SXT Pharmaceuticals Inc (NASDAQ: SXTC ) Equillium Inc (NASDAQ: EQ ) Medtronic PLC (NYSE: MDT ) Obseva SA (NASDAQ: OBSV ) Rhythm Pharmaceuticals Inc (NASDAQ: RYTM ) TRACON Pharmaceuticals Inc (NASDAQ: TCON ) Trevi Therapeutics Inc (NASDAQ: TRVI ) Zimmer Biomet Holdings Inc (NYSE: ZBH ) Stocks In Focus Roche Extends Offer Period For Spark Buy Once Again Roche Holdings AG Basel ADR (OTC: RHHBY ) and Spark Therapeutics Inc (NASDAQ: ONCE ) announced Wednesday Roche has extended the offering period for its previously announced tender offer to buy all outstanding shares of Spark for $114.50 …
   TRACON to Report First Quarter 2020 Financial Results and Company Highlights on May 13, 2020  2020/05/06 20:05:00 GlobeNewswire
SAN DIEGO, May 06, 2020 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development…
   Tracon stock rises on cancer development partnerships  2019/12/20 13:58:00 MarketWatch
Shares of Tracon Pharmaceuticals Inc. were up 29% in premarket trading on Friday after the company said it would partner with two Chinese companies to…
   TRACON Pharmaceuticals (NASDAQ:TCON) Releases Quarterly Earnings Results, Beats Estimates By $0.03 EPS  2019/11/07 15:51:11 Modern Readers
TRACON Pharmaceuticals (NASDAQ:TCON) announced its quarterly earnings results on Tuesday. The biopharmaceutical company reported ($0.17) earnings per share for the quarter, beating the consensus estimate of ($0.20) by $0.03, Fidelity Earnings reports. NASDAQ TCON traded down $0.02 during trading hours on Thursday, reaching $0.40. The company had a trading volume of 368 shares, compared to […]
   Tracon Pharma Shares Rally As First Patient Dosed In Cancer Trial  2019/08/01 15:33:40 Benzinga
Shares of the thinly traded nanocap biotech TRACON Pharmaceuticals Inc (NASDAQ: TCON ) were rallying Thursday. What Happened Tracon, which specializes in novel therapeutics for cancer, said it has dosed the first patient in a U.S. Phase 1 first-in-human clinical trial of I-Mab's proprietary CD73 antibody TJD5, also known as TJ004309, in patients with advanced solid tumors. TJD5 is from Chinese biopharma stable and it is being co-developed through a corporate collaboration between Tracon and I-Mab that was signed in November 2018. TJD5 will be dosed in the Phase 1 trial both as a single agent … Full story available on Benzinga.com
   The Daily Biotech Pulse: Roche-Spark Deal Faces Further Delay, Bayer's Prostate Cancer Drug Passes FDA Muster  2019/07/31 11:06:00 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on July 30) Acasti Pharma Inc (NASDAQ: ACST ) ANI Pharmaceuticals Inc Common Stock (NASDAQ: ANIP ) Arcturus Therapeutics Ltd (NASDAQ: ARCT ) Hologic, Inc. (NASDAQ: HOLX ) Insulet Corporation (NASDAQ: PODD ) Medpace Holdings Inc (NASDAQ: MEDP )(reported strong second-quarter results ) Novocure Ltd (NASDAQ: NVCR ) ZIOPHARM Oncology Inc. (NASDAQ: ZIOP ) Down In The Dumps (Biotech stocks hitting 52-week lows on July 30) Alimera Sciences Inc (NASDAQ: ALIM )(reacted to second-quarter results) ANCHIANO THERAP/S ADR (NASDAQ: ANCN ) Aquestive Therapeutics Inc (NASDAQ: AQST ) Champions Oncology Inc (NASDAQ: CSBR ) China SXT Pharmaceuticals Inc (NASDAQ: SXTC ) Equillium Inc (NASDAQ: EQ ) Medtronic PLC (NYSE: MDT ) Obseva SA (NASDAQ: OBSV ) Rhythm Pharmaceuticals Inc (NASDAQ: RYTM ) TRACON Pharmaceuticals Inc (NASDAQ: TCON ) Trevi Therapeutics Inc (NASDAQ: TRVI ) Zimmer Biomet Holdings Inc (NYSE: ZBH ) Stocks In Focus Roche Extends Offer Period For Spark Buy Once Again Roche Holdings AG Basel ADR (OTC: RHHBY ) and Spark Therapeutics Inc (NASDAQ: ONCE ) announced Wednesday Roche has extended the offering period for its previously announced tender offer to buy all outstanding shares of Spark for $114.50 …

calendar